MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1

Vascular Pharmacology

Volumn 88, Issue , 2017, Pages 48-55

  Tang, Song tao ^a   Wang, Feng ^a   Shao, Min ^a   Wang, Yuan ^a   Zhu, Hua qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Diabetes; High mobility group box 1; Inflammation; MiR 126

Indexed keywords

ANTAGOMIR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; MICRORNA; MICRORNA 126; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL NUCLEOLAR RNA; TUMOR NECROSIS FACTOR; APOLIPOPROTEIN E; MESSENGER RNA; MIRN126 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; ANIMAL; DOWN REGULATION; EXPERIMENTAL DIABETES MELLITUS; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GLUCOSE; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TRANSFECTION;

EID: 85008147293     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2016.12.002     Document Type: Article

References (28)

1. [1] Cannon, C.P., Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone 9 (2008), 24–41.
2. [2] Li, M.F., Zhao, C.C., Li, T.T., Tu, Y.F., Lu, J.X., Zhang, R., et al. The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes. Cardiovasc. Diabetol., 15, 2016, 43.
3. [3] Xu, R.S., Pathogenesis of diabetic cerebral vascular disease complication. World J. Diabetes, 6, 2015, 54.
4. [4] Osiecki, H., The role of chronic inflammation in cardiovascular disease and its regulation by nutrients. Altern. Med. Rev. 9 (2004), 32–53.
5. [5] Nagareddy, P., Smyth, S.S., Inflammation and thrombosis in cardiovascular disease. Curr. Opin. Hematol., 20, 2013, 457.
6. [6] Gounis, M.J., van der Marel, K., Marosfoi, M., Mazzanti, M.L., Clarencon, F., Chueh, J.Y., et al. Imaging inflammation in cerebrovascular disease. Stroke 46 (2015), 2991–2997.
7. [7] Dinh, W., Füth, R., Nickl, W., Krahn, T., Ellinghaus, P., Scheffold, T., et al. Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc. Diabetol., 8, 2009, 58.
8. [8] Ahlin, F., Arfvidsson, J., Vargas, K.G., Stojkovic, S., Huber, K., Wojta, J., MicroRNAs as circulating biomarkers in acute coronary syndromes: a review. Vasc. Pharmacol., Apr 12, 2016.
9. [9] Hartmann, D., Thum, T., MicroRNAs and vascular (dys)function. Vasc. Pharmacol. 55 (2011), 92–105.
10. [10] Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 100 (2007), 1579–1588.
11. [11] Rangrez, A.Y., Massy, Z.A., Metzinger-Le Meuth, V., Metzinger, L., MiR-143 and miR-145 molecular keys to switch the phenotype of vascular smooth muscle cells. Circ. Cardiovasc. Genet. 4 (2011), 197–205.
12. [12] Wang, S., Aurora, A.B., Johnson, B.A., Qi, X., McAnally, J., Hill, J.A., et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15 (2008), 261–271.
13. [13] Harris, T.A., Yamakuchi, M., Ferlito, M., Mendell, J.T., Lowenstein, C.J., MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 1516–1521.
14. [14] Hu, J., Zeng, L., Huang, J., Wang, G., Lu, H., miR-126 promotes angiogenesis and attenuates inflammation after contusion spinal cord injury in rats. Brain Res. 1608 (2015), 191–202.
15. [15] Andrews, C.N., Bharucha, A.E., Camilleri, M., Low, P.A., Seide, B., Burton, D., et al. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007), G1359–G1365.
16. [16] Zhu, H., Shan, L., Peng, T., Rac1 mediates sex difference in cardiac tumor necrosis factor-α expression via NADPH oxidase–ERK1/2/p38 MAPK pathway in endotoxemia. J. Mol. Cell. Cardiol. 47 (2009), 264–274.
17. [17] Li, Y., Arnold, J.M.O., Pampillo, M., Babwah, A.V., Peng, T., Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation. Free Radic. Biol. Med. 46 (2009), 51–61.
18. [18] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2 (− Delta Delta C(T)) method. Methods 25 (2001), 402–408.
19. [19] Urbich, C., Kuehbacher, A., Dimmeler, S., Role of microRNAs in vascular diseases, inflammation and angiogenesis. Cardiovasc. Res. 79 (2008), 581–588.
20. [20] Fish, J.E., Santoro, M.M., Morton, S.U., Yu, S., Yeh, R.F., Wythe, J.D., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15 (2008), 272–284.
21. [21] Wang, Y., Wang, F., Wu, Y., Zuo, L., Zhang, S., Zhou, Q., et al. MicroRNA-126 attenuates palmitate-induced apoptosis by targeting TRAF7 in HUVECs. Mol. Cell. Biochem. 399 (2015), 123–130.
22. [22] Magna, M., Pisetsky, D.S., The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol. Med., 20, 2014, 138.
23. [23] Feuerstein, G.Z., Liu, T., Barone, F.C., Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. Brain Metab. Rev. 6 (1993), 341–360.
24. [24] Yao, H., Yang, S., Kode, A., Rajendrasozhan, S., Caito, S., Adenuga, D., et al. Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. Biochem. Soc. Trans., 35, 2007, 1151.
25. [25] Huang, H.N., Lu, P.J., Lo, W.C., Lin, C.H., Hsiao, M., Tseng, C.J., In situ Akt phosphorylation in the nucleus tractus solitarii is involved in central control of blood pressure and heart rate. Circulation 110 (2004), 2476–2483.
26. [26] Paterniti, I., Esposito, E., Mazzon, E., Bramanti, P., Cuzzocrea, S., Evidence for the role of PI3-kinase-AKT-eNOS signalling pathway in secondary inflammatory process after spinal cord compression injury in mice. Eur. J. Neurosci. 33 (2011), 1411–1420.
27. [27] Mammi, C., Pastore, D., Lombardo, M.F., Ferrelli, F., Caprio, M., Consoli, C., et al. Sildenafil reduces insulin-resistance in human endothelial cells. PLoS One, 6, 2011, e14542.
28. [28] Chen, W., Qi, J., Feng, F., Wang, M.D., Bao, G., Wang, T., et al. Neuroprotective effect of allicin against traumatic brain injury via Akt/endothelial nitric oxide synthase pathway-mediated anti-inflammatory and anti-oxidative activities. Neurochem. Int. 68 (2014), 28–37.